Mathew Aby J.'s Form 4 filing
Biolife Solutions Inc (BLFS) · filed Oct 14, 2025
- Accession no.
- 0001628280-25-045017
- Filed
- Oct 14, 2025
- Trade date
- Oct 9, 2025
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $13.9K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mathew Aby J.CIK 0001556355 | Officer (EVP & Chief Scientific Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 9, 2025 | Common Stock | SSaleDisposed | −509 | $27.36 | −$13,926.24 | 350,912 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.